ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,335Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 2680

$1.74M Total Retail Price of All Prescriptions

Rank: 7 out of 2680

1,187 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 1,187 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 1,187 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 28,660 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 1,500 1,404 1 7
LEVOTHYROXINE SODIUM 1,418 1,315 2 4
METOPROLOL TARTRATE 1,281 1,184 3 8
CITALOPRAM HBR 1,126 958 4 22
LISINOPRIL 896 806 5 5
HYDROCODONE-ACETAMINOPHEN 848 745 S3 6 13
OMEPRAZOLE 840 730 7 2
JANTOVEN 749 703 8 81
AMLODIPINE BESYLATE 714 663 9 3
MIRTAZAPINE 632 602 10 48
DIVALPROEX SODIUM 562 449 11 90
RANITIDINE HCL 541 442 12 35
POTASSIUM CHLORIDE 515 478 13 29
GABAPENTIN 503 418 14 21
WARFARIN SODIUM 473 413 15 12
DONEPEZIL HCL 471 441 16 28
NAMENDA 364 327 17 43
LANTUS 346 295 18 70
RISPERIDONE 341 303 19 67
TAMSULOSIN HCL 329 251 20 25
METOPROLOL SUCCINATE 325 301 21 11
CYMBALTA 323 240 22 56
TRAZODONE HCL 317 273 23 60
ISOSORBIDE MONONITRATE ER 312 306 24 57
PAROXETINE HCL 296 242 25 62
LACTULOSE 289 249 26 100
SANTYL 286 215 27 144
LEVETIRACETAM 284 206 28 94
CARBIDOPA-LEVODOPA 282 249 29 88
QUETIAPINE FUMARATE 276 248 30 72
HYDRALAZINE HCL 276 273 30 99
BACLOFEN 255 111 32 123
POLYETHYLENE GLYCOL 3350 245 223 33 55
CARVEDILOL 237 229 34 27
METFORMIN HCL 236 181 35 6
METHADONE HCL 225 176 S2 36 201
ATENOLOL 217 168 37 14
PANTOPRAZOLE SODIUM 215 209 38 44
TRAMADOL HCL 212 191 39 33
VALPROIC ACID 207 167 40 221
SERTRALINE HCL 197 160 41 23
PREDNISONE 196 169 42 45
DIGOXIN 194 190 43 59
SPIRONOLACTONE 191 181 44 86
GLIPIZIDE 188 169 45 71
SIMVASTATIN 186 161 46 1
CLONIDINE HCL 178 159 47 84
KLOR-CON M20 161 156 48 101
SULFAMETHOXAZOLE-TRIMETHOPRIM 157 127 49 137
DIOVAN 153 136 50 26
IPRATROPIUM-ALBUTEROL 148 129 51 110
SPIRIVA 145 141 52 36
ADVAIR DISKUS 143 134 53 32
OLANZAPINE 142 102 54 128
CLOPIDOGREL 134 126 55 30
ABILIFY 125 105 56 192
HYDROCHLOROTHIAZIDE 125 112 56 9
KLOR-CON M10 125 116 56 185
MORPHINE SULFATE 118 113 S2 59 256
ALLOPURINOL 117 112 60 42
OXYBUTYNIN CHLORIDE 114 85 61 189
NOVOLIN R 114 99 61 210
CHLORHEXIDINE GLUCONATE 111 74 63 166
DIVALPROEX SODIUM ER 109 107 64 257
VANCOMYCIN HCL 106 98 65 274
DILTIAZEM 24HR CD 102 102 66 148
NOVOLIN N 101 99 67 279
PLAVIX 101 96 67 41
NYSTATIN-TRIAMCINOLONE 100 78 69 140
SEROQUEL 100 95 69 161
LIDODERM 100 97 69 74
PHENYTOIN SODIUM EXTENDED 98 81 72 207
LOSARTAN POTASSIUM 98 98 72 18
CIPROFLOXACIN HCL 97 83 74 85
FAMOTIDINE 97 84 74 65
SODIUM CHLORIDE 97 91 74 475
BUMETANIDE 96 80 77 225
NEXIUM 93 46 78 19
HYDROCORTISONE 92 75 79 208
NOVOLIN 70-30 92 77 79 277
LATANOPROST 92 92 79 195
NYSTOP 91 73 82 183
ESCITALOPRAM OXALATE 91 62 82 82
NYSTATIN 91 77 82 160
OXYBUTYNIN CHLORIDE ER 89 42 85 135
CEPHALEXIN 89 76 85 132
METOLAZONE 86 79 87 262
FENTANYL 84 79 S2 88 102
HYDROXYZINE HCL 84 64 R 88 212
HALOPERIDOL 83 77 90 153
LAMOTRIGINE 83 40 90 232
TRAVATAN Z 83 74 90 234
METOCLOPRAMIDE HCL 80 58 93 150
GENTAMICIN SULFATE 80 59 93 399
FINASTERIDE 76 76 95 80
SILVER SULFADIAZINE 75 63 96 227
CLOZAPINE 73 59 97 226
EXELON 73 73 97 162
CEFTRIAXONE 72 57 99 272
LEVOFLOXACIN 71 66 100 108
ATORVASTATIN CALCIUM 71 47 100 10
CRESTOR 70 60 102 15
PRAVASTATIN SODIUM 70 65 102 16
DOXAZOSIN MESYLATE 70 70 102 127
OLANZAPINE ODT 69 57 105 444
LOVASTATIN 68 36 106 37
VENTOLIN HFA 65 61 107 61
LYRICA 65 54 107 107
ALENDRONATE SODIUM 65 55 107 20
FLUOXETINE HCL 65 36 107 76
OXCARBAZEPINE 63 45 111 382
OXYCODONE-ACETAMINOPHEN 63 42 S2 111 106
NITROGLYCERIN PATCH 63 53 111 171
MUPIROCIN 62 39 114 152
ROPINIROLE HCL 62 47 114 143
CEFPODOXIME PROXETIL 61 52 116 356
COMBIVENT 60 55 117 129
HUMULIN R 59 54 118 328
ENALAPRIL MALEATE 58 58 119 24
FLUDROCORTISONE ACETATE 57 40 120 406
AZITHROMYCIN 56 43 121 40
PROPRANOLOL HCL 55 53 122 158
FLUTICASONE PROPIONATE 54 22 123 38
SINGULAIR 53 46 124 64
TIMOLOL MALEATE 53 53 124 366
DILANTIN 52 44 126 312
LIDOCAINE HCL 52 45 126 251
NOVOLOG 51 22 128 159
LIDOCAINE 51 48 128 186
IBUPROFEN 51 42 128 63
SYMBICORT 50 50 131 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.